LIVZON PHARMAC. GRP H YC1 (LP6) — Net Asset Momentum
LIVZON PHARMAC. GRP H YC1 (LP6) recorded a net asset momentum of 4.3% as of December 2025, with net assets of €15.55 Billion EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See LIVZON PHARMAC. GRP H YC1 (LP6) liquidity interval to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
LIVZON PHARMAC. GRP H YC1 Net Asset Momentum (2021–2025)
This chart tracks LIVZON PHARMAC. GRP H YC1's year-over-year net asset growth across 5 annual reporting periods from 2021 to 2025. The most recent momentum reading is +4.3%, with net assets of €15.55 Billion EUR as of December 2025. Read LIVZON PHARMAC. GRP H YC1 (LP6) total liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for LIVZON PHARMAC. GRP H YC1 (2021–2025)
The table below shows the complete annual net asset history for LIVZON PHARMAC. GRP H YC1 from 2021 to 2025, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see LP6 market cap overview.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | €15.55 Billion | €23.99 Billion | €8.44 Billion | ▲ +4.3% |
| 2024 | €14.91 Billion | €24.46 Billion | €9.55 Billion | ▲ +0.9% |
| 2023 | €14.77 Billion | €25.04 Billion | €10.28 Billion | ▼ -1.1% |
| 2022 | €14.94 Billion | €24.87 Billion | €9.93 Billion | ▲ +4.4% |
| 2021 | €14.31 Billion | €22.37 Billion | €8.06 Billion | — |